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Vaccine production with adherent cell lines faces multiple challenges which include selection of a suitable 
vessel, detachment of cells for scale up, optimization of infection, as well as harvest of virus particles. 
Microcarriers greatly increase the surface area for adherent cells and offer flexibility for expansion to 
bioreactors, but scale-up methods require optimization of bead-to-bead transfer. Even though the majority of cell 
culture based vaccines are produced with adherent cell lines, literature provides limited information in regards to 
optimization of adherent cell line processes. Some process improvements have been achieved; for example, 
recent advances in serum free media which no longer require medium exchange prior to virus infection. In this 
study we focus on the production of the rabies virus surrogate, vesicular stomatitis virus, in Vero cells. Using 
Cytodex-1 microcarriers in spinner flasks, we evaluated effects of intermittent and continuous stirring, 
detachment of cells, variation in the addition of new microcarriers on the growth of Vero cells, and effects on 
vesicular stomatitis virus production. Viable cell density measurements revealed that initial intermittent stirring 
resulted in increased cell densities compared to continuous stirring after microcarrier addition. In an effort to 
further simplify the process, we demonstrate that detachment of cells was not required to facilitate bead-to-bead 
transfer on Cytodex-1 microcarriers.   
 
